FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981569792> ?p ?o ?g. }

• W2981569792 abstract "Abstract Background Advanced pacemakers feature atrial antitachycardia pacing (aATP) therapies for terminating atrial arrhythmia. Previous studies showed the efficacy of combined atrial preventive pacing and aATP in patients with pacemakers. The independent effect of aATP and the impact for patients outside the clinical trials has not been well elucidated. Methods In a single center, prospective, all-comers trial, we enrolled 567 patients implanted cardiac devices with Reactive ATP function. History of permanent atrial fibrillation (AF) was not included. After device interrogation of the AF burden and the longest AF duration in the last 6 months, aATP was programmed as a bit more aggressive setting than MINERVA trial (time interval was set as every 2 hours). As for newly implanted devices, aATP was activated after at least 3 months run-in period. Primary and secondary outcomes were the longest AF duration and cumulative percentage of progression into permanent AF, respectively. Results Of 541 eligible patients, aged 75.3±10.7 years, 356 pacemaker, 82 ICD and 103 CRT patients, the longest single episode of AF lasted ≤6 min in 439 patients (81.1%), >6 min to 6 h in 43 (8.0%), >6–24 h in 33 (6.1%), and >24 h in 26 (4.8%) at the enrollment. During mean follow-up of 1.9 years, the longest AF episode lasted >24 h in 49 patients (9.1%) and 14 patients (2.6%) progressed into permanent AF. According with baseline longest single episode of AF, patients with AF ≤6 min developed an episode >24 h in 0.8% at 1 year and 3.2% at 2 years follow up; patients with AF >6 min to 6 h developed an episode >24 h in none at 1 year and 7% at 2 years follow up; and patients with AF >6–24 h developed an episode >24 h in 19% at 1 year and 42% at 2 years follow up, respectively. In a subgroup analysis of in 192 patients with at least 1 aATP, 46 patients with high efficacy (>44%) did not developed an episode >24 h. Only one patient developed into permanent AF without aATP therapy. On multivariate analysis, neither ICD nor CRT was independent risk factor for developing the longest AF episode >24 h. Conclusions The independent use of aATP without atrial preventive pacing was effective for preventing AF progression in a real world cohort. Even without the previous AF episodes, aATP could prevent AF development, especially in patients showing high aATP efficacy. Future research is required to enhance the aATP success rate." @default.
• W2981569792 created "2019-11-01" @default.
• W2981569792 creator A5002027683 @default.
• W2981569792 creator A5002233395 @default.
• W2981569792 creator A5037903905 @default.
• W2981569792 creator A5044319117 @default.
• W2981569792 creator A5059960901 @default.
• W2981569792 date "2019-10-01" @default.
• W2981569792 modified "2023-09-27" @default.
• W2981569792 title "P6544A real world study of high frequency atrial anti-tachycardia pacing in new algorithm for atrial arrhythmia" @default.
• W2981569792 doi "https://doi.org/10.1093/eurheartj/ehz746.1134" @default.
• W2981569792 hasPublicationYear "2019" @default.
• W2981569792 type Work @default.
• W2981569792 sameAs 2981569792 @default.
• W2981569792 citedByCount "0" @default.
• W2981569792 crossrefType "journal-article" @default.
• W2981569792 hasAuthorship W2981569792A5002027683 @default.
• W2981569792 hasAuthorship W2981569792A5002233395 @default.
• W2981569792 hasAuthorship W2981569792A5037903905 @default.
• W2981569792 hasAuthorship W2981569792A5044319117 @default.
• W2981569792 hasAuthorship W2981569792A5059960901 @default.
• W2981569792 hasConcept C11413529 @default.
• W2981569792 hasConcept C126322002 @default.
• W2981569792 hasConcept C164705383 @default.
• W2981569792 hasConcept C2776131983 @default.
• W2981569792 hasConcept C2779161974 @default.
• W2981569792 hasConcept C2779422446 @default.
• W2981569792 hasConcept C2780283014 @default.
• W2981569792 hasConcept C2988455589 @default.
• W2981569792 hasConcept C41008148 @default.
• W2981569792 hasConcept C71924100 @default.
• W2981569792 hasConceptScore W2981569792C11413529 @default.
• W2981569792 hasConceptScore W2981569792C126322002 @default.
• W2981569792 hasConceptScore W2981569792C164705383 @default.
• W2981569792 hasConceptScore W2981569792C2776131983 @default.
• W2981569792 hasConceptScore W2981569792C2779161974 @default.
• W2981569792 hasConceptScore W2981569792C2779422446 @default.
• W2981569792 hasConceptScore W2981569792C2780283014 @default.
• W2981569792 hasConceptScore W2981569792C2988455589 @default.
• W2981569792 hasConceptScore W2981569792C41008148 @default.
• W2981569792 hasConceptScore W2981569792C71924100 @default.
• W2981569792 hasLocation W29815697921 @default.
• W2981569792 hasOpenAccess W2981569792 @default.
• W2981569792 hasPrimaryLocation W29815697921 @default.
• W2981569792 hasRelatedWork W141049456 @default.
• W2981569792 hasRelatedWork W1499959474 @default.
• W2981569792 hasRelatedWork W1571458613 @default.
• W2981569792 hasRelatedWork W1976733529 @default.
• W2981569792 hasRelatedWork W1988070711 @default.
• W2981569792 hasRelatedWork W1990788345 @default.
• W2981569792 hasRelatedWork W1991309218 @default.
• W2981569792 hasRelatedWork W1997518118 @default.
• W2981569792 hasRelatedWork W2019995120 @default.
• W2981569792 hasRelatedWork W2028306425 @default.
• W2981569792 hasRelatedWork W2065582951 @default.
• W2981569792 hasRelatedWork W2152707193 @default.
• W2981569792 hasRelatedWork W2157582776 @default.
• W2981569792 hasRelatedWork W2261113503 @default.
• W2981569792 hasRelatedWork W2277730308 @default.
• W2981569792 hasRelatedWork W2287409230 @default.
• W2981569792 hasRelatedWork W2292064780 @default.
• W2981569792 hasRelatedWork W2401422608 @default.
• W2981569792 hasRelatedWork W2583821224 @default.
• W2981569792 hasRelatedWork W2966228378 @default.
• W2981569792 isParatext "false" @default.
• W2981569792 isRetracted "false" @default.
• W2981569792 magId "2981569792" @default.
• W2981569792 workType "article" @default.